BDTX

Broke outConviction 65LongHealthcareScan · Wed, Oct 21, 2026

Falling trendline breakSpinning topchannel

Black Diamond Therapeutics, Inc. (BDTX) closed at $2.10 (+1.45%) on Oct 21, 2026. It is in the "Broke out" lane with a falling trendline break pattern. Price is above its 50-day and below its 200-day moving average. RSI(14) 64, RS Rating 28, -56.9% from its 52-week high, -15.7% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

BDTX$2.10+1.45%

ResistanceSupportVol 14

Vol MA14 934.23K

Jul 24Aug 11Aug 28Sep 16Oct 5Oct 21

Trade plan

LongReward : Risk0.59

Entry

2.10

Risk

Stop

1.82

-13.5% to stop

Reward

Target 1

2.27

+8.0% to target

Stretch

Target 2

2.43

+15.9% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Black Diamond Therapeutics, Inc.Biological Products, (No Diagnostic Substances)www.blackdiamondtherapeutics.com ↗

Price2.10

Change+1.45%

Gap-0.48%

Rel volume3.45×

Avg volume797.88K

Avg $ vol1.5M

SMA 201.85

SMA 501.98

SMA 2002.22

Price vs 50+5.86%

Price vs 200-5.52%

MA stackmixed

50/200 cross—

Supertrendup · 1.71

RSI (14)64

MACD hist0.03

MACD crossbull · 1d

Stoch %K / %D93 / 79

ADX (14)21

+DI / −DI30 / 15

RSI divergence—

MACD divergence—

ATR %5.38%

ADR %5.51%

52w high4.87

52w low1.61

From 52w high-56.88%

Above 52w low+30.43%

New 52w highNo

SqueezeOff

Bollinger width22.67%

%B1.11

Donchian pos92.59%

Donchian high2.14

Donchian low1.60

AVWAP (52w high)2.45

vs AVWAP high-14.20%

AVWAP (52w low)1.89

vs AVWAP low+11.22%

OBV trendUp

Chaikin MF (20)0.26

Today vs 20d3.45×

Avg vol (14d)934.23K

Avg vol (20d)797.88K

Avg $ vol (20d)1.5M

Market cap—

RS Rating28 / 99

RS 3m (vs SPY)+9.40%

RS 6m (vs SPY)-46.02%

RS line new highNo

Trend template3/8

Technical rank55.1

1 week+23.53%

1 month+6.06%

3 months+14.13%

6 months-37.31%

1 year-48.91%

YTD-15.66%

P/E5.34

P/B1.24

P/S1.71

P/FCF4.04

EPS0.3900

Div yield—

ROE23.28%

ROA17.89%

Debt/Eq—

Current7.28

EV/EBITDA—

Gross margin—

Net margin31.95%

Rev growth—

EPS growth132.10%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value100.31M

Revenue0

Net income-9.9M

Gross profit—

Free cash flow29.61M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out57.3M

Employees21

ListedThu, Jan 30, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction65 / 100

Pattern quality55%

Tech rank55.1 / 100

Group rank23 / 100

Status laneBroke out

Setup directionLong

Pattern familyChannel

Resistance1.99

Support1.71

Days since event1d

Candle confirmSpinning top

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BDTX

All disclosures →

No recent disclosed trades by Congress in BDTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BDTX

Insider	Side	Shares	Value	Traded	Filed
Behbahani Ali Director · Common Stock · 2026-09-18	Grant	7.71K	$15K	2026-09-18	2026-09-21
Raman Prakash Director · Common Stock · 2026-09-18	Grant	6.8K	$13K	2026-09-18	2026-09-21
Behbahani Ali Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Dhingra Kapil Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Menzel Garry E Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Kulkarni Samarth Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Raman Prakash Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Campbell Shannon Director · Stock Option (Right to Buy) · 2026-06-26	Grant	40K	—	2026-06-26	2026-06-29
Behbahani Ali Director · Common Stock · 2026-06-19	Grant	8.96K	$15K	2026-06-19	2026-06-22
Raman Prakash Director · Common Stock · 2026-06-19	Grant	7.91K	$13K	2026-06-19	2026-06-22

SEC filings

EDGAR filings in BDTX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

BDTX

Trade plan

Recent news

Get daily signals & real-time alerts.